LOS ANGELES–(BUSINESS WIRE)–The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Brown-Forman Corporation (“Brown-Forman” or “the Company”) (NYSE: BF-A, BF-B) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Brown-Forman reported its financial results for fiscal year 2025 on June 5, 2025. The Company reported a decline in year-over-year sales of 7.3% and earnings per share below consensus estimates. The Company stated its “results did not meet our long-term growth aspirations,” and advised investors that “looking ahead to fiscal 2026, we expect continued headwinds.”
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm’s website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
Contacts
The Schall Law Firm
Brian Schall, Esq.
310-301-3335
info@schallfirm.com
www.schallfirm.com
PUNE, India, Oct. 15, 2025 /PRNewswire/ -- The ASM Group of Institutes, a pioneer in industry-integrated…
BANGALORE, India and MYSURU, India and MONTPELLIER, France, Oct. 15, 2025 /PRNewswire/ -- ChipSync, a…
A Historic Milestone in Extreme Rallying Conditions at High Altitudes Backed by JK Tyre, India's…
The Bay at Ecoworld, Brookfield Properties’ flagship food and cultural hub in Bengaluru, came alive…
For the first time in history, four Indian cities - Delhi, Mumbai, Bengaluru, and Ahmedabad…
India’s pharmaceutical landscape is undergoing a vital transformation. Despite being home to one of the…